CYP2C19 and Gilbert syndrome: It should also be considered that the phenotype of other genes that could alter the metabolism of the study drugs are not considered an exclusion criterion, e.g., PM for CYP2C19 or ultrarrapid metabolizers (UMs) for CYP2D6, but UGT1A1 as a cause of Gilbert’s syndrome is considered even though it is a benign disease.